04:23 AM EST, 01/13/2025 (MT Newswires) -- Medtronic ( MDT ) said Monday it received CE Mark approval for its BrainSense Adaptive Deep Brain Stimulation and BrainSense Electrode Identifier, a Parkinson's disease therapy device, in the European Union and the UK.

The company said the approval confirms that the devices meet the EU medical device regulation standards.